Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R41/R42 Clinical Trial Not Allowed)
ID: PAR-21-226Type: BOTH
Overview

Topic

Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R41/R42 Clinical Trial Not Allowed)

Agency

Department of Health and Human ServicesNational Institutes of Health

Program

Type: STTRPhase: BOTHYear: 2021

Topic Link

https://www.sbir.gov/node/1972475

Additional Information

https://grants.nih.gov/grants/guide/PA-files/PAR-21-226.html
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of novel tools and devices to improve animal welfare and support animal model research. The goal is to enhance the management of individual animals and animal colonies, as well as monitor and control environmental conditions that can affect research outcomes. The variation in environmental factors between different animal facilities has been identified as a source of irreproducibility in animal research. Therefore, the agency is looking for devices that can accurately monitor challenging environmental conditions such as humidity, vibrations, odors, and ultrasonic noise. Additionally, there is a need for noninvasive or minimally invasive bio-logging devices for real-time monitoring of animal behavior, food/water consumption, and bodily functions. The development of new software that can combine data from different monitoring devices and link to existing databases is also desired. The agency emphasizes the importance of innovation and encourages the adaptation of technologies from other fields to improve animal research. The solicitation is open for Small Business Technology Transfer (STTR) projects, and the application due dates are provided on the grants.gov website. For more information, interested parties can visit the solicitation agency URL.

    Files
    No associated files provided.
    Similar Opportunities
    Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of technologies to address health-related social needs that impact substance use disorders (SUD), excluding alcohol use disorder. The goal is to fill the service gaps that government and the medical community cannot address alone. The technologies should focus on reducing costs, time, and/or increasing access in addressing housing instability, non-medical transportation, food insecurity, utility needs, and personal safety. The products should provide feasible and accessible opportunities for end-users to improve their health-related social needs and SUD outcomes. The solicitation is open for Phase I and Fast-Track (Phase I/Phase II) applications, with a focus on establishing technical feasibility and commercial potential. The application due date is March 13th, 2024, with subsequent due dates in 2025 and 2026. More information can be found on the grants.gov website.
    HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of therapies and technologies directed at enhanced pain management through the Small Business Technology Transfer (STTR) program. The focus of this solicitation is on improving pain measurement and treatment. The goal is to address the national opioid public health crisis by providing alternative treatment options for chronic pain, which affects over 25 million Americans. The research objectives include the development of tools and technologies to understand the biological underpinnings of chronic pain, the discovery and pre-clinical development of non-addictive analgesic treatments, and the advancement of new pain treatments through the clinical pipeline. The solicitation is open to various fields, including biology, medicine, engineering, and technology. The project duration can vary, and the funding specifics can be found on the grants.gov website. The open date for submissions is December 4, 2022, and the close date is April 5, 2025. For more information and to access the solicitation, visit the provided links.
    Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of technologies to address health-related social needs that impact substance use disorders (SUD), excluding alcohol use disorder. The goal is to fill the service gaps that government and the medical community cannot address alone. The technologies should focus on reducing costs, time, and/or increasing access in addressing housing instability, non-medical transportation, food insecurity, utility needs, and personal safety. The products should provide feasible and accessible opportunities for end-users to improve their health-related social needs and SUD outcomes. The solicitation is open for Phase I and Phase II applications, including Fast-Track applications that combine both phases. The deadline for submission is March 14, 2026. For more information, visit the solicitation agency URL: link.
    Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the "Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities" topic. This solicitation aims to engage and support small businesses in developing technologies, services, and products that improve minority health and reduce health disparities in underserved populations. The research objectives include enhancing disease self-management, promoting health-seeking behaviors, detecting and assessing unhealthy social and environmental exposures, utilizing digital health technologies, strengthening healthcare infrastructure, and empowering individuals and communities. The solicitation is open for applications until December 10, 2026, and funding specifics can be found on the grants.gov website. For more information, refer to the solicitation agency URL provided.
    NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required). This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The funding opportunity is open until September 6, 2026. For more information and to apply, visit the solicitation agency URL: link.
    NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required). This solicitation aims to support small business concerns (SBCs) in conducting exploratory clinical trials that contribute to the justification for future trials to establish definitive efficacy. The trials can include Phase 1 and 2 studies of drugs and biologics, feasibility and preliminary efficacy studies of devices, as well as early studies of surgical, behavioral, or rehabilitation therapies. The trials can be single-site or multi-site with up to three clinical sites. The applications must generate data that inform further clinical development of the proposed intervention or diagnostic, and FDA approval is required for FDA-regulated clinical trials. The goal is to advance products/technologies that require federal regulatory approval or bring complex research tools to market. The funding opportunity is open until September 6, 2026. For more information and to apply, visit the solicitation agency URL: link.
    Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the "Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities" topic. This solicitation aims to engage and support small businesses in developing technologies, services, and products that improve minority health and reduce health disparities in underserved populations. The research objectives include enhancing disease self-management, promoting health-seeking behaviors, detecting and assessing unhealthy social and environmental exposures, utilizing digital health technologies, strengthening healthcare infrastructure, and empowering individuals and communities. The solicitation is open for applications until December 10, 2026, and funding specifics can be found on the grants.gov website.
    Miniaturization and Automation of Tissue Chip Systems (MATChS) (U43/U44 Clinical Trial Not Allowed)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the Miniaturization and Automation of Tissue Chip Systems (MATChS) through their SBIR program. The goal of this funding opportunity is to support the development of benchtop, portable, automated systems that maintain 3D tissue constructs and provide biologically relevant outputs of tissue health and function. The technology should be easy to use, have integrated sensors, and enable rapid and reproducible high-throughput analysis. The project should also focus on automation and miniaturization, with the potential for remote monitoring and real-time biosensing. The funding opportunity is open for Phase I, Phase II, Fast-Track, and Direct to Phase II grant applications. The project duration spans multiple years, with application due dates in February of each year. More information can be found on the grants.gov website.
    Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R41/R42 Clinical Trial Optional)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the development of regulated therapeutic and diagnostic solutions for patients affected by opioid and/or stimulant use disorders (OUD/StUD). The current drug crisis surrounding these disorders has resulted in a significant number of deaths and an urgent need for comprehensive solutions. The solicitation is focused on the research and development of medical products regulated by the U.S. Food and Drug Administration (FDA), including pharmacotherapeutics and medical therapeutic and diagnostic devices. In the area of pharmacotherapeutics, the solicitation encourages the development of small or large molecule agents, biologics, natural products, longer-acting formulations of existing addiction medications, advanced drug delivery systems, and the development and characterization of biomarkers. Proposed activities may include target identification, assay development, lead optimization, preclinical studies, formulation development, and process development. The ultimate goal is to file an Investigational New Drug (IND) application and conduct clinical studies to support the filing of a New Drug Application (NDA) or a Biological License Application (BLA). In the area of medical therapeutic and diagnostic devices, the solicitation seeks research and development of imaging technologies, devices for diagnosing and reducing craving and withdrawal symptoms, therapeutic devices, devices for treating pediatric patients, in vitro diagnostic assays, digital therapeutics, devices for detecting and treating opioid-induced respiratory depression, and data science and cloud-based technologies. Proposed activities may include studies supporting an Investigational Device Exemption application, process development, non-clinical safety studies, clinical trials, and engagement with the FDA Center of Devices and Radiological Health. The goal is to successfully file an FDA premarket application for clearance/approval. The solicitation is open for applications and offers funding for Phase I, Phase II, and Fast Track projects. Phase I aims to establish the technical merit and feasibility of the proposed research, while Phase II continues the R&D efforts to advance the technology toward commercialization. Fast Track applications combine Phase I and Phase II into one application to reduce or eliminate the funding gap between phases. Small businesses that have received Phase I STTR awards are eligible to submit Phase II applications as "Renewal" applications.
    Miniaturization and Automation of Tissue Chip Systems (MATChS) (UT1/UT2 - Clinical Trial Not Allowed)
    Active
    Department of Health and Human Services
    The Department of Health and Human Services, specifically the National Institutes of Health, is seeking proposals for the Miniaturization and Automation of Tissue Chip Systems (MATChS) through a Small Business Technology Transfer (STTR) program. The goal of this funding opportunity is to support the development of bench top, portable, automated, self-contained systems that maintain 3D tissue constructs and provide biologically relevant outputs of tissue health and function. The technology should be able to automate tissue preculture and loading, system operation, perfusion systems, and cell culture conditions. It should also include in-line sensors for monitoring and sensing, as well as software for instrument control and data processing. The system should be cost-effective, mass producible, and robust. The performance of the system should be characterized and validated, and the applicant should propose quantitative metrics for evaluating progress. The long-term goal is to achieve technological advances that enable the routine use of tissue chips in safety and efficacy assessment of therapeutics. The funding opportunity is open for Phase I, Phase II, and Fast-Track grant applications, with a project duration of up to 2 years. The application due dates are February 22, 2024, February 24, 2025, and February 23, 2026. More information can be found on the grants.gov website.